Infections of the ascomycete fungi Trichophyton spp. (e.g., onychomycosis or nail fungus, tinea pedis or athlete's foot, tinea corporus or ringworm) are some of the oldest human dermatological afflictions. Whilst not life-threatening, these infections can be of significant annoyance to the sufferer. T. rubrum is the most common dermatophyte infection in healthy individuals, accounting for up to 70% of skin infections (1) and up to 90% of nail infections (2, 3) . Nail infections caused by T. rubrum affects around 10% of the population and are frequently intractable and prone to relapse upon termination of antifungal therapy (4, 5) . T. rubrum infections of hair, skin and nails have increased over the past 70 years, especially in the elderly and in some countries also in children (6) (7) (8) . Chronic skin infections caused by T. rubrum can become sites for secondary infection by other microorganisms, such as Candida spp., Cryptococcus spp., Aspergillus spp. and have been developed using photosensitizers in combination with UVA-1 radiation (340-400 nm) to kill both the mycelial form and conidia of T. rubrum (13) in topical dermal infections. The most commonly used antifungal agents against T. rubrum are ketoconazole, fluconazole, terbinafine and flucytosine (13) . The prolonged treatment regimens often required have led to the emergence of azole resistant T. rubrum strains, especially against fluconazole (14) (15) (16) (17) .
In this study, we characterize the catalytic properties of recombinant T.
rubrum CYP51 and compare the novel antifungal VT-1161 (18, 19) with clinical azole antifungal drugs in terms of potency and selectivity of binding to and inhibition of recombinant T. rubrum CYP51 and in inhibition of fungal growth in broth microdilution assays. Fig. 2B ), suggesting eburicol binds in only one conformation that causes the displacement of the axial ligated heme water molecule responsible for the low-to high-spin state transition. (Table 1) confirmed the potency of VT-1161, as the MICs ranged from less than or equal to the lowest concentration tested (0.03 µg ml -1 ) to the highest MIC values of 0.06
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µg ml -1 . VT-1161's MIC50, MIC90 and geometric mean values of <0.03, 0.06, and 0.033 µg ml -1 were slightly less than those for itraconazole (0.06, 0.06, and 0.052
µg ml -1 , respectively), and both of these CYP51 inhibitors were significantly more potent that fluconazole (2, 16, and 2.3 µg ml -1 , respectively). The GM MICs of VT-1161 and itraconazole were both significantly lower than that of fluconazole (p = 0.0018 for both comparisons) but were not significantly different between each other.
Phylogenetic comparison of fungal CYP51 enzymes. The primary amino acid sequence of T. rubrum CYP51 contained all twenty-three conserved CYP51 residues previously identified by Lepesheva and Waterman (27) in addition to the conserved heme-binding cysteine residue (supplementary figure S1). The degree of conservation between the six-substrate recognition sites (SRSs) (28) varied (supplementary figure S1) with SRS-1 being the most conserved and SRS-6 the least conserved. Both T. rubrum and M. graminicola CYP51 enzymes can turnover eburicol but not lanosterol (this study; 23). A.
fumigatus CYP51 isoenzymes A and B turnover both eburicol and lanosterol, albeit with a 4-to 7-fold preference for eburicol in terms of measured velocity using purified proteins (29) or more than an 18-fold preference for eburicol using membrane fractions. C. albicans, C. neoformans and M. globosa CYP51 enzymes, on the other hand, all readily turnover both eburicol and lanosterol (29) (30) (31) . Analysis of the amino acid sequences of the six SRSs between the seven fungal CYP51 enzymes did not identify any residue changes that could be directly linked to the change in substrate specificity observed in the T. rubrum and M. graminicola CYP51 enzymes.
DISCUSSION
In preparation for studying antifungal inhibitors of this enzyme, we have Tight binding is normally observed where the Kd for a ligand is similar or lower than the concentration of the enzyme present (54) . 
